News Equipping the NHS for a digital future
Healthcare technology is evolving faster than ever, and Clinical Engineering teams are at the heart of helping the NHS embrace innovation, while maintaining safe, effective and efficient patient care. That is why professionals from across the NHS and industry are set to come together at the NPAG Clinical Engineering Conference 2026, themed “Smart Hospitals – Equipping & Digital Transformation.” The conference will explore how technology,
digital systems and innovative approaches can help healthcare organisations improve efficiency, enhance patient outcomes, support digital transformation and align with the ambitions of the NHS 10-Year Plan. As hospitals become increasingly connected and reliant on sophisticated medical equipment, the role of Clinical Engineering and Healthcare Technology teams has never been more important.
Designed as a practical, NHS-led event, the
conference will bring together clinical engineers, biomedical engineers, healthcare technology managers, researchers, academics and industry partners to share experiences, discuss challenges and showcase real-world solutions. Delegates can expect a programme focused on practical application, implementation and shared learning, with sessions highlighting how innovation is already delivering benefits across healthcare organisations. A key focus of the event will be the growing role
best practice from across the healthcare sector. Alongside the conference sessions, delegates
of Clinical Engineering teams in supporting digital transformation. From connected medical devices and asset management systems to interoperability, cybersecurity and smart infrastructure, healthcare technology professionals are increasingly becoming strategic enablers of modern healthcare delivery. The conference will provide an opportunity to hear how organisations are overcoming common challenges and delivering measurable improvements through technology. The speaker programme is currently being finalised, with NHS leaders, healthcare technology specialists and industry experts expected to share insights and case studies aligned to the conference theme. Organisers are also exploring opportunities to bring international perspectives to the agenda, ensuring delegates gain exposure to innovation and
will have access to a substantial exhibition featuring leading healthcare technology suppliers, medical device manufacturers and service providers. The exhibition is designed to give attendees hands-on access to the latest products, technologies and solutions, while creating valuable opportunities to engage directly with industry experts. Interest from exhibitors has been exceptionally strong, with significant stand space already secured well in advance of the event. The expo will showcase innovations spanning medical devices, healthcare technology management, digital solutions, equipment maintenance services and more, offering delegates a unique opportunity to explore emerging technologies in one location. Networking remains one of the most highly
valued aspects of the NPAG Clinical Engineering Conference. The event provides dedicated opportunities for delegates to connect with peers from across the UK, exchange ideas, discuss challenges and build professional relationships that continue long after the conference has ended. Join NPAG on 22 September 2026, at the Radisson
Blu, Stansted, and be part of the conversation driving the next generation of smart hospitals. For further information and to register, visit:
https://www.npag.org.uk/clinical-engineering- conference-2026
Hampshire Hospitals recognised for outstanding Myeloma care
Hampshire Hospitals NHS Foundation Trust has been recognised nationally for its outstanding care of patients with myeloma after receiving a prestigious award from leading charity, Myeloma UK. The Myeloma UK’s Clinical Service Excellence Programme (CSEP) Award has been presented to the Haematology Team at Basingstoke and North Hampshire Hospital celebrating the achievements in delivering high quality treatment and care to their patients and identifying any key areas of improvement. Hampshire Hospitals first achieved the accreditation in 2022. Myeloma is an incurable type of blood cancer that affects plasma cells in the bone marrow and requires ongoing specialist treatment and support. Developed by Myeloma UK in consultation with patients, family members, carers and healthcare professionals, the charity’s CSEP programme best practice standards comprise of ten key themes, covering all aspects of myeloma, from referral and diagnosis to end-of-life care. Hampshire Hospitals achieved an ‘excellent’ rating in all ten categories. Myeloma UK also highlighted the hospital’s
fears with them. They listen and support you and put you back on your feet again. You can say things to them that you really wouldn’t say to your family, because you wouldn’t want to worry them. They’re just incredible. And I thank them from the bottom of my heart.” Rhys Owens, Clinical Practice Services Senior
Myeloma Walk and Talk sessions as an example of innovative patient support, bringing together exercise, peer support and mental wellbeing activities for people living with the condition. Dr. Noel Ryman, Consultant Haematologist at Hampshire Hospitals, said: “We are very proud to be reaccredited by Myeloma UK and to have achieved an excellent rating across all categories. This award reflects the dedication of our entire multidisciplinary team, who work together to provide the highest standard of care and support for people living with myeloma.” Sarah Walker, a myeloma patient at Hampshire Hospitals, said: “The doctors and nurses are always here for you. You can share your anxieties and
Projects Officer at Myeloma UK, said: “Myeloma is a challenging cancer which keeps coming back and can be difficult to cope with both physically and mentally, so patients really need a caring team in their corner. “A particular standout is the hospital’s new ‘Myeloma Walk and Talk’ sessions which combine exercise with mental wellbeing and peer support. It’s absolute clear to us that staff work very hard to empower patients, listen to their needs, and actively encourage them to participate in decisions about their care.” The reaccreditation reinforces Hampshire Hospitals’ commitment to ensuring patients with myeloma receive high-quality, personalised care throughout their treatment journey.
September 2026 I
www.clinicalservicesjournal.com 11
Father_Studio -
stock.adobe.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85